Dinuclear RuII complexes with quinonoid bridges: tuning the electrochemical and spectroscopic properties of redox-switchable NIR dyes through judicious bridge design
Abstract
Bridging quinonoid ligands are important platforms for generating metal-based switchable optoelectronic and magnetic materials. A possible sound way of influencing the properties of the aforementioned materials is to modify the direct metal-ligand interface. We present herein a series of dinuclear RuII complexes where the set of donor atoms at the bridging quinonoid ligands range from [O,O,O,O], [O,O,O,N], [O,N,O,N] and [O,N,O,N']. Additionally, the substituents on the N-donors were varied as well (a total of eight different quinonoid bridges are compared). We also present a mononuclear RuII complex for comparison purposes. The dinuclear complexes act as switchable NIR dyes, absorbing in the NIR region in their mixed-valent RuII/RuIII form but not in the neighboring RuII/RuII and RuIII/RuIII states. The switching potentials (the potentials at which NIR absorptions appear) and the λmax of the NIR band can be fine-tuned by varying the donor atoms as well as the electron-donating ability of the substituents on the nitrogen atoms (tuning E by ca. 0.4 V and λmax by ca. 450 nm). Introducing more electron-rich substituents at the nitrogen atoms of the bridge results in higher band energies and more cathodic redox potentials. Unsymmetr...Continue Reading
References
Thermally and light-induced valence tautomeric transition in a dinuclear cobalt-tetraoxolene complex
Citations
Methods Mentioned
Software Mentioned
Related Concepts
Related Feeds
Anti-Arrhythmic Drug Therapies
Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.